Literature DB >> 27902321

The serology of Ebolavirus - a wider geographical range, a wider genus of viruses or a wider range of virulence?

Magdalena Formella1, Derek Gatherer1.   

Abstract

Viruses of the genus Ebolavirus are the causative agents of Ebola virus disease (EVD), of which there have been only 25 recorded outbreaks since the discovery of Zaire and Sudan ebolaviruses in the late 1970s. Until the west African outbreak commencing in late 2013, EVD was confined to an area of central Africa stretching from the coast of Gabon through the Congo river basin and eastward to the Great Lakes. Nevertheless, population serological studies since 1976, most of which were carried out in the first two decades after that date, have suggested a wider distribution and more frequent occurrence across tropical Africa. We review this body of work, discussing the various methods employed over the years and the degree to which they can currently be regarded as reliable. We conclude that there is adequate evidence for a wider geographical range of exposure to Ebolavirus or related filoviruses and discuss three possibilities that could account for this: (a) EVD outbreaks have been misidentified as other diseases in the past; (b) unidentified, and clinically milder, species of the genus Ebolavirus circulate over a wider range than the most pathogenic species; and (c) EVD may be subclinical with a frequency high enough that smaller outbreaks may be unidentified. We conclude that the second option is the most likely and therefore predict the future discovery of other, less virulent, members of the genus Ebolavirus.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27902321     DOI: 10.1099/jgv.0.000638

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.

Authors:  Anna Bratcher; Nicole A Hoff; Reena H Doshi; Adva Gadoth; Megan Halbrook; Patrick Mukadi; Kamy Musene; Benoit Ilunga-Kebela; D'Andre Spencer; Matthew S Bramble; David McIlwan; J Daniel Kelly; Daniel Mukadi; Placide Mbala Kingebeni; Steve Ahuka; Emile Okitolonda-Wemakoy; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  PLoS Negl Trop Dis       Date:  2021-08-12

2.  Serological Detection of Ebola Virus Exposures in Native Non-human Primates of Southern Nigeria.

Authors:  B N Ogunro; B O Olugasa; E J Verschoor; A O Olarinmoye; I Theyse; H Niphuis
Journal:  J Epidemiol Glob Health       Date:  2018-12

3.  Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo.

Authors:  Nicole A Hoff; Patrick Mukadi; Reena H Doshi; Matthew S Bramble; Kai Lu; Adva Gadoth; Cyrus Sinai; D'Andre Spencer; Bradley P Nicholson; Russell Williams; Matthias Mossoko; Benoit Ilunga-Kebela; Joseph Wasiswa; Emile Okitolonda-Wemakoy; Vivian H Alfonso; Imke Steffen; Jean-Jacques Muyembe-Tamfum; Graham Simmons; Anne W Rimoin
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

4.  Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey.

Authors:  Joseph W S Timothy; Yper Hall; Joseph Akoi-Boré; Boubacar Diallo; Thomas R W Tipton; Hilary Bower; Thomas Strecker; Judith R Glynn; Miles W Carroll
Journal:  Lancet Infect Dis       Date:  2019-02-21       Impact factor: 25.071

5.  Characterization and analytical validation of a new antigenic rapid diagnostic test for Ebola virus disease detection.

Authors:  Céline Couturier; Atsuhiko Wada; Karen Louis; Maxime Mistretta; Benoit Beitz; Moriba Povogui; Maryline Ripaux; Charlotte Mignon; Bettina Werle; Adrien Lugari; Delphine Pannetier; Sabine Godard; Anne Bocquin; Stéphane Mely; Ismaël Béavogui; Jean Hébélamou; David Leuenberger; Philippe Leissner; Takeshi Yamamoto; Patrick Lécine; Christophe Védrine; Julie Chaix
Journal:  PLoS Negl Trop Dis       Date:  2020-01-17

6.  Development of a multiplex microsphere immunoassay for the detection of antibodies against highly pathogenic viruses in human and animal serum samples.

Authors:  Rebecca Surtees; Daniel Stern; Katharina Ahrens; Nicole Kromarek; Angelika Lander; Petra Kreher; Sabrina Weiss; Roger Hewson; Emma K Punch; John N Barr; Peter T Witkowski; Emmanuel Couacy-Hymann; Andrea Marzi; Brigitte G Dorner; Andreas Kurth
Journal:  PLoS Negl Trop Dis       Date:  2020-10-23

7.  Risk Factors for Ebola Exposure in Health Care Workers in Boende, Tshuapa Province, Democratic Republic of the Congo.

Authors:  Reena H Doshi; Nicole A Hoff; Anna Bratcher; Patrick Mukadi; Adva Gadoth; Bradly P Nicholson; Russell Williams; Daniel Mukadi; Matthias Mossoko; Joseph Wasiswa; Alexis Mwanza; Cyrus Sinai; Vivian H Alfonso; Rupal Shah; Matthew S Bramble; Benoit Ilunga-Kebela; Emile Okitolonda-Wemakoy; Jean Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  J Infect Dis       Date:  2022-09-04       Impact factor: 7.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.